Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000945808 | SCV001091865 | likely benign | Gorlin syndrome; Medulloblastoma | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002320160 | SCV002609275 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478593 | SCV004221300 | likely benign | not provided | 2023-07-20 | criteria provided, single submitter | clinical testing |